About MicuRx
Our company
Our Team
Vision & mission
History
Contact Us
Scientific research
Antibiotic Resistance
Kidney Disease
MicuRx R&D
Publications
Pipeline
Newsroom
Corporate news
Careers
Contact Us
中
Scientific research
Home
Publications
Antibiotic Resistance
Kidney Disease
MicuRx R&D
Publications
Contezolid can replace linezolid in a novel combination with bedaquiline and pretomanid in a murine model of tuberculosis
Antimicrobial Agents and Chemotherapy / 2024
View Publication
Preclinical toxicity evaluation of novel antibacterial contezolid acefosamil in rats and dogs
J Appl Toxicol / 2024
View Publication
Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmacokinetic/pharmacodynamic analysis
Sec. Pharmacology of Infectious Diseases / 2023
View Publication
In vivo pharmacodynamic study of contezolid acefosamil, a prodrug of contezolid for oral and intravenous administration
Journal of Antimicrobial Chemotherapy / 2023
View Publication
A phase I study of the safety, tolerability, and pharmacokinetics of contezolid acefosamil after intravenous and oral administration in healthy Chinese subjects
Antimicrobial Agents and Chemotherapy / 2023
View Publication
In vivo pharmacodynamic study of contezolid acefosamil, a prodrug of contezolid for oral and intravenous administration
Journal of Antimicrobial Chemotherapy / 2023
View Publication
A Novel Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Expresses Anti-Mycobacterium abscessus Activity In Vitro and In Vivo
Antimicrobial Agents and Chemotherapy / 2022
View Publication
Discovery of Antibacterial Contezolid Acefosamil: Innovative O-Acyl Phosphoramidate Prodrug for IV and Oral Therapies
ACS Med. Chem. Lett. / 2022
View Publication
Clinical Pharmacology and Utility of Contezolid in Chinese Patients with Complicated Skin and Soft-Tissue Infections
Antimicrobial Agents and Chemotherapy / 2022
View Publication
A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections
Journal of Antimicrobial Chemotherapy / 2022
View Publication
A Novel Oxazolidinone, Contezolid (MRX-I), Expresses Anti-Mycobacterium abscessus Activity In Vitro
Antimicrobial Agents and Chemotherapy / 2021
View Publication
Pharmacokinetics and Disposition of Contezolid in Humans: Resolution of a Disproportionate Human Metabolite for Clinical Development
Antimicrobial Agents and Chemotherapy / 2021
View Publication
1
2
3
>
Close